These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2663975)

  • 41. Characteristics of responders to fluoxetine.
    Reimherr FW; Wood DR; Byerley B; Brainard J; Grosser BI
    Psychopharmacol Bull; 1984; 20(1):70-2. PubMed ID: 6371874
    [No Abstract]   [Full Text] [Related]  

  • 42. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
    Keller MB; Lavori PW; Goldenberg IM; Baker LA; Pollack MH; Sachs GS; Rosenbaum JF; Deltito JA; Leon A; Shear K
    J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression.
    Feighner JP; Boyer WF; Meredith CH; Hendrickson GG
    Int Clin Psychopharmacol; 1989 Jul; 4(3):239-44. PubMed ID: 2507630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A fixed-dose clinical trial of fluoxetine in outpatients with major depression.
    Fabre LF; Putman HP
    J Clin Psychiatry; 1987 Oct; 48(10):406-8. PubMed ID: 3312176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial.
    Berman RM; Anand A; Cappiello A; Miller HL; Hu XS; Oren DA; Charney DS
    Biol Psychiatry; 1999 May; 45(9):1170-7. PubMed ID: 10331109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression.
    Lydiard RB; Laird LK; Morton WA; Steele TE; Kellner C; Laraia MT; Ballenger JC
    Psychopharmacol Bull; 1989; 25(1):68-70. PubMed ID: 2505304
    [No Abstract]   [Full Text] [Related]  

  • 49. Severity of depression and response to fluoxetine.
    Pande AC; Sayler ME
    Int Clin Psychopharmacol; 1993; 8(4):243-5. PubMed ID: 8277142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Placebo response in depression: a search for predictors.
    Brown WA; Dornseif BE; Wernicke JF
    Psychiatry Res; 1988 Dec; 26(3):259-64. PubMed ID: 3065807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluoxetine versus imipramine.
    Loeb C; Albano C; Gandolfo C
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():75-9. PubMed ID: 2783703
    [No Abstract]   [Full Text] [Related]  

  • 52. The pharmacotherapy of minor depression.
    Stewart JW; Quitkin FM; Klein DF
    Am J Psychother; 1992 Jan; 46(1):23-36. PubMed ID: 1543251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A double blind comparison of lofepramine, imipramine and placebo in patients with depression.
    Feighner JP; Meridith CH; Dutt JE; Hendrickson GG
    Acta Psychiatr Scand; 1982 Aug; 66(2):100-8. PubMed ID: 6753500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nefazodone: aspects of efficacy.
    Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
    J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amoxapine and imipramine in the treatment of depressed outpatients: a controlled study.
    Rickels K; Case WG; Werblowsky J; Csanalosi I; Schless A; Weise CC
    Am J Psychiatry; 1981 Jan; 138(1):20-4. PubMed ID: 7446776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluoxetine versus amineptine in the treatment of outpatients with major depressive disorders.
    Ferreri M
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():97-101. PubMed ID: 2644344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia.
    Heiligenstein JH; Tollefson GD; Faries DE
    Int Clin Psychopharmacol; 1993; 8(4):247-51. PubMed ID: 8277143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy in long-term treatment of depression.
    Montgomery SA
    J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
    Ucha Udabe R; Márquez CA; Traballi CA; Portes N
    Acta Psychiatr Scand Suppl; 1990; 360():54-6. PubMed ID: 2123367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E; Feighner J; Mandos LA; Rickels K
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.